Monthly Tezepelumab injections helped 90% of severe asthma patients cut steroid use, with many seeing improved symptoms and ...

Discover the phase 3 trial results for a monthly injection designed to help asthma sufferers reduce or cease their use of ...

A new injection, tezepelumab, could help severe asthma patients to stop oral steroids safely. It could reduce steroid-related ...

A monthly injection could enable severe asthma patients to stop taking daily steroid tablets without affecting their symptoms ...

Dupilumab reduces mucus plugging and improves lung function in patients with moderate-to-severe type 2 asthma.

Tezepelumab was given the go-ahead for NHS use by the National Institute for Health and Care Excellence (Nice) in 2023 ...

Small airway dysfunction is common in adult well-controlled asthma and is independently linked to increased risk for future exacerbations.

The Hailie Smartinhaler, from med-tech company Adherium, improves asthma control by ensuring inhalers are used effectively and at the right time. It has been assisting American asthmatics since 2017; ...

Please provide your email address to receive an email when new articles are posted on . Remission of childhood onset asthma may be due to a change in environment. Biologics have “changed the landscape ...

A new asthma treatment, depemokimab, has shown promise in reducing exacerbations while maintaining a strong safety profile, according to findings presented at the 2025 American Academy of Allergy, ...

Asthma is common. Around 10 percent of Americans have the condition, with hundreds of millions more asthmatics worldwide. Though the ubiquity of asthma may be concerning in and of itself, it's a ...

A monthly injection has helped 90% of severe asthma (chronic inflammatory lung disease) patients reduce daily steroid tablets ...